BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 2820317)

  • 1. Arachidonic acid and LTB4 enhance aggregation of psoriatic peripheral blood mononuclear leukocytes in vitro.
    Pigatto PD; Polenghi MM; Altomare GF; Tadini GL; Villa S
    Arch Dermatol Res; 1987; 279(5):347-50. PubMed ID: 2820317
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Arachidonic acid and leukotriene B4 induce aggregation of human peripheral blood mononuclear leucocytes in vitro.
    Villa S; Colotta F; de Gaetano G; Semeraro N
    Br J Haematol; 1984 Sep; 58(1):137-46. PubMed ID: 6087875
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Platelet aggregating substance from mononuclear leukocytes.
    Lazzari MA; Schattner MA; Finiasz M; Gimeno M
    Prostaglandins Leukot Med; 1986 Jun; 22(3):275-84. PubMed ID: 3088602
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vitamin E and vitamin C inhibit arachidonate-induced aggregation of human peripheral blood leukocytes in vitro.
    Villa S; Lorico A; Morazzoni G; de Gaetano G; Semeraro N
    Agents Actions; 1986 Oct; 19(1-2):127-31. PubMed ID: 3099558
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Arachidonic acid metabolism by polymorphonuclear leukocytes in psoriasis.
    Maurice PD; Bather PC; Allen BR
    Br J Dermatol; 1986 Jan; 114(1):57-64. PubMed ID: 3002416
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Calcium dependent aggregation of marine sponge cells is provoked by leukotriene B4 and inhibited by inhibitors of arachidonic acid oxidation.
    Rich AM; Weissmann G; Anderson C; Vosshall L; Haines KA; Humphreys T; Dunham P
    Biochem Biophys Res Commun; 1984 Jun; 121(3):863-70. PubMed ID: 6331432
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of inhibitors of arachidonic acid metabolism on intercellular adhesion of SV40-3T3 cells.
    Evans PM; Lanham DF
    Cell Biol Int Rep; 1986 Sep; 10(9):693-8. PubMed ID: 3019579
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neutrophil aggregating properties of PAF-acether and leukotriene B4.
    Ford-Hutchinson AW
    Int J Immunopharmacol; 1983; 5(1):17-21. PubMed ID: 6302012
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biosynthesis of lipoxygenase products by enzyme preparations from normal and psoriatic skin.
    Ziboh VA; Casebolt TL; Marcelo CL; Voorhees JJ
    J Invest Dermatol; 1984 Dec; 83(6):426-30. PubMed ID: 6094672
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of LTB4 binding to human neutrophils by nordihydroguaiaretic acid.
    Maloff BL; Fefer D; Cooke GM; Ackerman NR
    Agents Actions; 1987 Aug; 21(3-4):358-60. PubMed ID: 2825484
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro study of frog adrenal function--IX. Evidence against the involvement of lipoxygenase metabolites in the control of steroid production.
    Delarue C; Lihrmann I; Feuilloley M; Netchitaïlo P; Idres S; Leboulenger F; Bélanger A; Perroteau I; Vaudry H
    J Steroid Biochem; 1988; 30(1-6):461-4. PubMed ID: 2838699
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acetyl glyceryl ether phosphorylcholine stimulates leukotriene B4 synthesis in human polymorphonuclear leukocytes.
    Lin AH; Morton DR; Gorman RR
    J Clin Invest; 1982 Nov; 70(5):1058-65. PubMed ID: 6290535
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolism of [14C]arachidonic acid by polymorphonuclear leukocytes in patients with psoriasis.
    Stüning M; Schultz-Ehrenburg U; Altmeyer P; Raulf M; König W
    Br J Dermatol; 1987 Feb; 116(2):153-9. PubMed ID: 3030388
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Topical steroid treatment reduces arachidonic acid and leukotriene B4 in lesional skin of psoriasis.
    Wong E; Barr RM; Cunningham FM; Mistry K; Woollard PM; Mallet AI; Greaves MW
    Br J Clin Pharmacol; 1986 Dec; 22(6):627-32. PubMed ID: 3032226
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acetyl glyceryl ether phosphorylcholine stimulates leukotriene B4 synthesis and cyclic AMP accumulation in human polymorphonuclear leukocytes.
    Gorman RR; Morton DR; Hopkins NK; Lin AH
    Adv Prostaglandin Thromboxane Leukot Res; 1983; 12():57-63. PubMed ID: 6303092
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of the effects of some compounds on human neutrophil degranulation and leukotriene B4 and thromboxane B2 synthesis.
    Palmer RM; Salmon JA
    Biochem Pharmacol; 1985 May; 34(9):1485-90. PubMed ID: 2986647
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential effects of lipoxygenase products on FMLP and LTB4 evoked neutrophil aggregation.
    Beckman JK; Gay JC; Brash AR; Lukens JN; Oates JA
    Lipids; 1985 Jun; 20(6):357-60. PubMed ID: 2991693
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human lymphocyte aggregation?
    Lazzari MA; Schattner MA; Finiasz M; Gimeno M
    Prostaglandins Leukot Med; 1984 Sep; 15(3):303-16. PubMed ID: 6436835
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The chemokinetic response of psoriatic and normal polymorphonuclear leukocytes to arachidonic acid lipoxygenase products.
    Cunningham FM; Wong E; Woollard PM; Greaves MW
    Arch Dermatol Res; 1986; 278(4):270-3. PubMed ID: 3017241
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endothelium-dependent inhibition of platelet aggregation.
    Azuma H; Ishikawa M; Sekizaki S
    Br J Pharmacol; 1986 Jun; 88(2):411-5. PubMed ID: 3089351
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.